Update from Guardion Health Sciences Inc. (GHSI): A steady trajectory

The closing price of Guardion Health Sciences Inc. (NASDAQ: GHSI) was $0.15 for the day, up 10.00% from the previous closing price of $0.14. In other words, the price has increased by $+0.0140 from its previous closing price. On the day, 1128484 shares were traded. GHSI stock price reached its highest trading level at $0.1700 during the session, while it also had its lowest trading level at $0.1413.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



Our analysis of GHSI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.10 and its Current Ratio is at 10.30. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 0.83 while its Price-to-Book (P/B) ratio in mrq is 0.36.

Stock Price History:

Over the past 52 weeks, GHSI has reached a high of $1.14, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is 0.1572, while the 200-Day Moving Average is calculated to be 0.1891.

Shares Statistics:

GHSI traded an average of 1.33M shares per day over the past three months and 538.5k shares per day over the past ten days. A total of 61.60M shares are outstanding, with a floating share count of 60.78M. Insiders hold about 1.34% of the company’s shares, while institutions hold 7.70% stake in the company. Shares short for GHSI as of Oct 13, 2022 were 5.86M with a Short Ratio of 5.50M, compared to 6.4M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 9.52% and a Short% of Float of 9.65%.

Earnings Estimates

The firm’s stock currently is rated by 1 analysts. The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.03 and low estimates of -$0.03.

Analysts are recommending an EPS of between -$0.15 and -$0.15 for the fiscal current year, implying an average EPS of -$0.15. EPS for the following year is -$0.13, with 1 analysts recommending between -$0.13 and -$0.13.

Revenue Estimates

Based on 2 analysts’ estimates, the company’s revenue will be $14.76M in the next fiscal year. The high estimate is $14.9M and the low estimate is $14.62M. The average revenue growth estimate for next year is up 18.10% from the average revenue estimate for this year.